Medkart Introduces India's First Room-Temperature Stable Nicorandil Tablets, Enhancing Accessibility to Cardiac Care
Friday, 23 May 2025
In a country where cardiac care costs continue to burden millions, Medkart introduces a game-changing innovation: India's first room-temperature stable generic Nicorandil tablets-making heart medication more accessible, affordable, and logistically convenient.Medkart, a leading generic medicine platform in India, proudly announces the launch of the nations most in-demand Nicorandil tablets which remain stable at room temperature. This innovation eliminates the need for cold-chain storage, reducing logistical challenges and making the medication more accessible and affordable for patients across diverse regions. The product is now available at all Medkart outlets.
*Refrigeration Not Required-India's First Room-Temperature Nicorandil is here**Addressing Storage Challenges in Cardiac Medications*
Nicorandil is widely prescribed for the treatment of chronic stable angina. Due to its sensitivity to temperature and humidity, its storage has traditionally required stringent cold-chain logistics. This requirement often poses significant challenges, especially in rural and semi-urban areas where maintaining cold-chain infrastructure is difficult.*Enhancing Affordability and Accessibility*
Medkarts room-temperature stable Nicorandil tablets are manufactured under WHO-GMP-certified facilities, ensuring high-quality standards. By eliminating the need for refrigeration, the company significantly reduces distribution costs, allowing the medication to be priced up to 80% lower than its branded counterparts.
"Our room-stable Nicorandil is more than a product-it's an answer to India's cold chain problem in heart care," said *Ankur Agarwal, Co-founder of Medkart*. "Were proving that innovation doesnt have to be expensive-it has to be relevant."*Dr Ramesh Mehta, a senior cardiologist based in Ahmedabad*, added, "Ensuring that a cardiac drug like Nicorandil remains effective without refrigeration is a major step forward, particularly for patients in remote regions. We've long seen efficacy compromised due to storage issues. This advancement will save lives and improve treatment consistency."*Tackling the Cardiovascular Disease Burden*
Cardiovascular diseases (CVDs) are a leading cause of mortality in India. According to the Global Burden of Disease Study, heart disease is the leading cause of death among women in India, accounting for almost 18% of all female deaths. Medkart's launch addresses both cost and accessibility in one formulation.*Product Availability*
Medkart's room-stable Nicorandil tablets are now available at over 35000+ pincodes and online at www.medkart.in.To illustrate the cost difference between branded and Medkarts generic versions of Nicorandil tablets, here's a comparative snapshot based on real-time Medkart data:*Product Type*
*Strength*
*Branded Price Per Tab (Rs.)*
*Medkart Price Per Tab (Rs.)*
*Savings (Rs.)*
*Savings (%)*
Nicorandil 10 MG Tablet
10 mg
Rs. 26.95
Rs. 5.2
Rs. 21.75
80.72%
Nicorandil 5 MG Tablet
5 mg
Rs. 16.5
Rs. 3.1
Rs. 13.4
81.21%*Prices are based on current Medkart data. Actual savings may vary.*About Medkart*
Founded in 2014, Medkart is committed to making affordable healthcare accessible to all-especially for chronic conditions like heart disease, diabetes, and hypertension where long-term medication is critical. With a growing network of over 100+ retail outlets across India and a seamless online platform, Medkart empowers people to compare medicine prices, access WHO-GMP-certified generics, and receive reliable guidance from trained pharmacists.Having served over 11 lakh families and facilitated savings of more than Rs. 600 crore to date, Medkart leverages a tech-first approach through tools like dosage comparison, molecule-based search, store locator, and in-app ordering. Grounded in transparency and trust, Medkart continues to redefine India's pharmaceutical ecosystem by making quality treatment affordable for all.
|
||||
|
|
||||
You Might Like |
||||
